Safety & Legality

    Kava for Anxiety: What the Clinical Research Says

    6 min read

    Kava has more clinical trial evidence behind it for anxiety than most herbal supplements, multiple studies and a Cochrane review have found it outperforms placebo. That's not the same as it being a replacement for professional care.

    This is a summary of clinical research, not medical advice. If you have a diagnosed anxiety disorder, talk to a doctor before using kava as part of your approach.

    Quick Takeaways
    A Cochrane review of 12 RCTs found kava extract outperformed placebo for anxiety Later trials, including 16-week studies, have generally supported this finding Adverse events in trials were mostly mild, transient, and infrequent Kava isn't part of standard clinical guidelines for anxiety disorders

    What the Cochrane Review Found

    A Cochrane systematic review by Pittler and Ernst examined 12 double-blind, randomized, placebo-controlled trials of kava extract for anxiety. A meta-analysis of seven of these trials found a statistically significant reduction in scores on the Hamilton Anxiety Rating Scale, a standard clinical measure, for kava compared to placebo. Adverse events reported across the trials were, in the review's own words, mild, transient, and infrequent. The reviewers also called for larger, more rigorous trials and better long-term safety data, a caveat worth taking seriously alongside the positive result.

    What Later Research Has Added

    Subsequent research has built on this. A 2013 double-blind, randomized, placebo-controlled trial led by researcher Jerome Sarris specifically tested kava for generalized anxiety disorder and found it effective. A later 2020 trial, extended to 16 weeks, a notably longer duration than most earlier studies, added further data on both effectiveness and tolerability over a more realistic treatment timeframe. A 2018 systematic review and meta-analysis reached broadly similar conclusions to the original Cochrane findings, and additionally noted a stronger response in younger and female participants across the studies reviewed, while flagging ongoing questions about longer-term use.

    Close-up of a kava plant leaf
    Safety & Legality

    See the Full Safety Picture

    What large-scale reviews say about kava's overall safety profile.

    Read the Full Guide

    Where the Evidence Falls Short

    Even with generally favorable results, the trial evidence has real limits. Many of the earlier trials were relatively small and short, exactly the kind of study the Cochrane reviewers themselves flagged as needing improvement. Standardization also varies between trials, different studies used different kava extracts and preparations, which makes it harder to say precisely what dose or form the evidence actually supports. Kava also isn't included in the clinical anxiety treatment guidelines of major psychiatric bodies like the Canadian Psychiatric Association, which reflects both this evidence-quality gap and the field's continued caution following the early-2000s liver-safety concerns.

    What This Means in Practice

    The trial evidence for kava and anxiety is genuinely more substantial than for many herbal supplements, but it doesn't make kava a validated clinical treatment or a substitute for professional care. If you have a diagnosed anxiety disorder, or symptoms significant enough that you're considering treatment, talk to a doctor rather than self-treating with kava alone. Kava also interacts with a range of anxiety medications, see Kava Interactions. This is a summary of research, not medical advice.

    Kava powder made from ground kava root
    Directory

    Find a Kava Bar, Shop, or Vendor Near You

    Browse verified kava bars, shops, and vendors, or connect directly with farms and suppliers at the source.

    Browse the Directory
    Common Questions

    Frequently Asked Questions About Kava and Anxiety

    Multiple randomized controlled trials and a Cochrane review have found kava extract outperforms placebo on standard anxiety rating scales. This isn't medical advice or a treatment recommendation.

    It isn't part of standard clinical guidelines from major psychiatric bodies, despite the favorable trial evidence, reflecting both evidence-quality concerns and continued caution around kava's safety history.

    Adverse events reported across the 12 reviewed trials were mostly mild, transient, and infrequent, though the reviewers called for more long-term safety data.

    Don't make this decision without a doctor. Kava interacts with many anxiety medications, and stopping prescribed treatment without medical guidance carries its own risks. See Kava Interactions.

    Many earlier trials were relatively short. More recent studies, including a 16-week trial, have extended this timeframe, adding useful data on longer-term use.